Featured Research

from universities, journals, and other organizations

Little evidence found to support use of PET-CT in primary bowel cancer, study finds

Date:
October 14, 2011
Source:
NIHR
Summary:
New research has found little evidence to support the use of PET-CT add-on imaging device in the pre-operative staging of bowel cancer.

Research published in Health Technology Assessment has found little evidence to support the use of PET-CT add-on imaging device in the pre-operative staging of bowel cancer.

Worldwide, large bowel colorectal cancer accounts for more than one million cancers per year. In the UK, bowel cancer is the third commonest malignancy behind lung and breast cancer.

Several diagnostic tests are used to assess the extent of a cancer; ultrasound, magnetic resonance imaging (MRI), computerised tomography (CT) and contrast enhanced computerised tomography (CT) scanning of the chest abdomen and pelvis as well as a full blood count and biochemical profile. These can all inform the prognosis prior to surgical resection. The presence of disease distant to the site of planned surgery impacts upon type and timing of treatments. Together, this wide variation in presentations and extents of treatments underpin the rationale for accurate pre-operative staging.

The research is funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme and led by Professor David Weller of the University of Edinburgh. The researchers reviewed existing evidence on the diagnostic accuracy and therapeutic impact of an add on of CT in combination with Positron Emission Tomography -- Computed Tomography (FDG PET-CT) scanning. Integrated FDG PET-CT equipment is the latest imaging technology to be used for the pre-operative staging of colorectal cancer.

The team found limited evidence to support the use of FDG PET-CT in the pre-operative staging of primary, recurrent and spreading of colorectal cancer. Although FDG PET-CT was shown to change patient management the data was divergent and the quality of research studied was generally poor. Studies reported inconsistent findings about the effect FDG PET-CT had on surgical management. In addition, it was found that the published research evaluating FDG PET-CT for primary and recurrent bowel colorectal cancer did not reflect routine UK clinical practice at this time.

However, the research did show that FDG PET-CT as an add-on imaging device is cost-effective in the pre-operative staging of recurrent colon, recurrent rectal and metastatic disease, but it was not cost -effective for primary colon or primary rectal cancers.

Professor Weller commented: "There is uncertainty about the value of using FDG PET-CT in the treatment of bowel colorectal cancer. Importantly, practitioners who access this imaging technology need to routinely collect data to enable audits of patient outcomes, including detection rate and any changes in management resulting from its use."


Story Source:

The above story is based on materials provided by NIHR. Note: Materials may be edited for content and length.


Journal Reference:

  1. J Brush, K Boyd, F Chappell, F Crawford, M Dozier, E Fenwick, J Glanville, H McIntosh, A Renehan, D Weller, M Dunlop. The value of FDG positron emission tomography/ computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation. Health Technology Assessment, 2011; 15 (35) DOI: 10.3310/hta15350

Cite This Page:

NIHR. "Little evidence found to support use of PET-CT in primary bowel cancer, study finds." ScienceDaily. ScienceDaily, 14 October 2011. <www.sciencedaily.com/releases/2011/10/111014080043.htm>.
NIHR. (2011, October 14). Little evidence found to support use of PET-CT in primary bowel cancer, study finds. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2011/10/111014080043.htm
NIHR. "Little evidence found to support use of PET-CT in primary bowel cancer, study finds." ScienceDaily. www.sciencedaily.com/releases/2011/10/111014080043.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Idaho Boy Helps Brother With Disabilities Complete Triathlon

Idaho Boy Helps Brother With Disabilities Complete Triathlon

Newsy (July 23, 2014) An 8-year-old boy helped his younger brother, who has a rare genetic condition that's confined him to a wheelchair, finish a triathlon. Video provided by Newsy
Powered by NewsLook.com
Thousands Who Can't Afford Medical Care Flock to Free US Clinic

Thousands Who Can't Afford Medical Care Flock to Free US Clinic

AFP (July 23, 2014) America may be the world’s richest country, but in terms of healthcare, the World Health Organisation ranks it 37th. Thousands turned out for a free clinic run by "Remote Area Medical" with a visit from the Governor of Virginia. Duration: 2:40 Video provided by AFP
Powered by NewsLook.com
Stone Fruit Listeria Scare Causes Sweeping Recall

Stone Fruit Listeria Scare Causes Sweeping Recall

Newsy (July 22, 2014) The Wawona Packing Company has issued a voluntary recall on the stone fruit it distributes due to a possible Listeria outbreak. Video provided by Newsy
Powered by NewsLook.com
Huge Schizophrenia Study Finds Dozens Of New Genetic Causes

Huge Schizophrenia Study Finds Dozens Of New Genetic Causes

Newsy (July 22, 2014) The 83 new genetic markers could open dozens of new avenues for schizophrenia treatment research. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins